Delaying measles jab raises risk of seizure; Vivaldi buys Baxter flu vaccine assets;

> Delaying a newborn's measles vaccination could increase risk of seizures, researchers report. Study

> Vivaldi Biosciences has bought flu vaccine assets from Baxter Healthcare ($BAX). Release (PDF)

> Cel-Sci and CRO Ergomed have signed a co-development deal for immunotherapy drug Multikine. Item

> Germany's immatics has raised $46 million for a Phase III trial of its cancer vaccine. News

> Taiwan expects to have an H7N9 vaccine by late next year. Article

> CSL is to buy back almost AU$1 billion of shares over the next 12 months. Piece

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.